UK markets closed

Stryker Corporation (SYK)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
341.73-0.66 (-0.19%)
At close: 04:00PM EDT
344.58 +2.85 (+0.83%)
After hours: 06:26PM EDT

Stryker Corporation

1941 Stryker Way
Portage, MI 49002
United States
269 385 2600

IndustryMedical Devices
Full-time employees52,000

Key executives

NameTitlePayExercisedYear born
Mr. Kevin A. LoboChairman, CEO & President5.7M33.71M1965
Mr. Glenn S. BoehnleinVP & CFO2.27M5.44M1962
Mr. Viju S. MenonGroup President of Global Quality & Operations1.68MN/A1968
Mr. J. Andrew PierceGroup President of MedSurg & Neurotechnology2.03M2.69M1974
Mr. Spencer S. StilesGroup President of Orthopaedics & Spine2.02M2.33M1977
Mr. William E. Berry Jr.VP & Chief Accounting OfficerN/AN/A1966
Mr. Robert C. CohenCTO and VP of Global R&D - Joint ReplacementN/AN/AN/A
Mr. Alan DouvilleVP, Chief Information Officer & Chief Information Security OfficerN/AN/AN/A
Mr. Jason BeachVice President of Finance & Investor RelationsN/AN/AN/A
Mr. Robert S. FletcherVP & Chief Legal Officer895.89kN/A1971
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Corporate governance

Stryker Corporation’s ISS governance QualityScore as of 1 July 2024 is 5. The pillar scores are Audit: 5; Board: 5; Shareholder rights: 6; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.